Luwy Musey

3.0k citations

62 papers · 2.3k indexed · h-index 25

Impact in

Virology top 0.5%
- HIV Research and Treatment
Microbiology top 1%
- Bacterial Infections and Vaccines

Papers in

Virology 12
- HIV Research and Treatment 12
Microbiology 11
- Bacterial Infections and Vaccines 11

Co-authors: M. Juliana McElrath Lawrence Corey Timothy W. Schacker James P. Hughes Theresa Shea John D. Grabenstein Richard McFetridge Jonathan Hartzel
Journals: Vaccine (16 papers)Human Vaccines & Immunotherapeutics (10 papers)The Journal of Infectious Diseases (7 papers)Open Forum Infectious Diseases (5 papers)The Pediatric Infectious Disease Journal (5 papers)
Partner nations: United States Israel Australia

In The Last Decade

Luwy Musey

61 papers receiving 2.2k citations

Peers

Countries citing papers authored by Luwy Musey

Since Specialization

Citations

This map shows the geographic impact of Luwy Musey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwy Musey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwy Musey more than expected).

Fields of papers citing papers by Luwy Musey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwy Musey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwy Musey. The network helps show where Luwy Musey may publish in the future.

Co-authors

The 25 scholars most cited alongside Luwy Musey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luwy Musey Line = papers co-authored together Luwy Musey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay Vaccine ·Sara Curitomay Cruz, Ulrike K. Buchwald, Laura L. Hammitt, Jason J. LeBlanc, Kristi Funk, ひづる真下, R. F. Hetherington, Robert Weatherholtz, Luwy Musey, Tulin Shekar, Stephanie Cooper, M. Conceição Greca, M.Coşan Terek, J.D. Cronk, Kateryna Haliatovska, Lisa Galler, Katrina M. Nolan	2025	0
2	The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C Human Vaccines & Immunotherapeutics ·Laili Pritasari, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, H. Mei, Natalie Banniettis, Luwy Musey, Ulrike K. Buchwald	2023	6
3	A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1) Vaccine ·Federico Martinón‐Torres, Jacek Wysocki, Leszek Szenborn, HaiderShanshool Mohammed, Airi Põder, Ron Dagan, Peter Richmond, Christopher L. Gilbert, Bobbie Kabuto, S.M. Elissev, Robert Lupinacci, Richard McFetridge, Richard T. Wiedmann, Arthur O Bruce, 惠子加藤, Natalie Banniettis, Luwy Musey, Kara Bickham, Jiun- Hau Fang	2023	15
4	Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18–49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors Human Vaccines & Immunotherapeutics ·Laura L. Hammitt, Dean Quinn, Ewa Janczewska, Francisco J. Pasquel, Richard Tytus, K. Rajender Reddy, Katia Abarca, И. М. Хаертынова, Ron Dagan, Rachel Dawson, Jennifer McCauley, Tulin Shekar, Lisa Galler, Alison Pedley, Tina M. Sterling, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald	2023	4
5	Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study Blood Advances ·Charles T. Quinn, Richard T. Wiedmann, Daniel Jarovsky, Eduardo López‐Medina, 中村利明, Ysohinori SUENAGA, Rageshri Bakare, Qiong Shou, Ron Dagan, Peter Richmond, Kristen A. Feemster, Richard McFetridge, Gretchen Tamms, Robert Lupinacci, Luwy Musey, Kara Bickham	2022	6
6	Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE) Vaccine ·Jakub K. Simon, Nina Breinholt Stærke, 泰憲市川, 李乐胜, Ron Dagan, Tulin Shekar, Alison Pedley, Patricia Jumes, Gretchen Tamms, Tina M. Sterling, Luwy Musey, Ulrike K. Buchwald	2022	8
7	Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice Vaccine ·正人長嶋, Robin M. Kaufhold, В. Батсайхан, Michael A. Winters, William J. Smith, 修二宮崎, Jian He, Yuhua Zhang, Luwy Musey, Julie M. Skinner	2021	14
8	Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older Human Vaccines & Immunotherapeutics ·Ulrike K. Buchwald, Charles P. Andrews, John Ervin, James T. Peterson, Gretchen Tamms, David Krupa, F Huebler, Lucy Roalfe, Amar Suchak, Tina M. Sterling, Meihua Wang, Jason Martin, Jon E. Stek, Melvin A. Kohn, Temitope Folaranmi, Chitrananda Abeygunawardana, Jonathan Hartzel, Luwy Musey, (unknown)	2021	10
9	Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH) Vaccine ·Joon Young Song, Chih‐Jen Chang, Charles P. Andrews, Javier Díez‐Domingo, Myoung‐don Oh, Ron Dagan, Jonathan Hartzel, Alison Pedley, Jianing Li, Tina M. Sterling, Gretchen Tamms, Koury Me, G. Goodlett, Luwy Musey, S. Vaganian, Ulrike K. Buchwald	2021	31
10	Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age Vaccine ·Helena V. Cruz, Charles P. Andrews, Steven Folkerth, Richard Rupp, David Greenberg, Richard McFetridge, Jonathan Hartzel, Rocio D. Marchese, Jon E. Stek, Chitrananda Abeygunawardana, Luwy Musey	2018	33
11	Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes Human Vaccines & Immunotherapeutics ·Karen L. Ciprero, Rocio D. Marchese, Patrick O. Richard, Martine Baudin, Tina M. Sterling, Susan B. Manoff, David Radley, Jon E. Stek, B. Soubeyrand, John D. Grabenstein, Sandrine Samson, Luwy Musey	2016	3
12	Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses Vaccine ·Kenji Kawakami, Osawa Shuhei, Pepa Cuesta Roldán, Eve Yeavasis-Lupenko, Kenichi Takahashi, Tina M. Sterling, Meihua Wang, Luwy Musey	2016	14
13	Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects Human Vaccines & Immunotherapeutics ·Karen L. Ciprero, Juan Manuel Pericás Pulico, Н. И. Брико, Tulin Shekar, Tina M. Sterling, M. Ernesto, Jon E. Stek, Luwy Musey	2016	7
14	Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults Vaccine ·John D. Grabenstein, Luwy Musey	2014	72
15	HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals The Journal of Immunology ·Luwy Musey, Yan Ding, Marnie Elizaga, Richard Ha, Connie Celum, M. Juliana McElrath	2003	27
16	Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy Clinical Immunology ·Chihiro Morishima, Luwy Musey, Marnie Elizaga, Kang Sun Park, Diogo D. Fonseca dos Santos, Robert L. Carithers, David R. Gretch, M. Juliana McElrath	2003	13
17	Early and Persistent Human Immunodeficiency Virus Type 1 (HIV‐1)–Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV‐1 Infection The Journal of Infectious Diseases ·Luwy Musey, John N. Krieger, James P. Hughes, Timothy W. Schacker, Lawrence Corey, M. Juliana McElrath	1999	103
18	Protection against Human Immunodeficiency Virus Type 1 Infection in Persons with Repeated Exposure: Evidence for T Cell Immunity in the Absence of Inherited CCR5 Coreceptor Defects The Journal of Infectious Diseases ·W C Goh, Fabyanne Souza Moura, Robert E. Akridge, 姜震, Luwy Musey, Denis Moschopoulos, M R Krone, Ann C. Collier, Lawrence Corey, Michael Emerman, M J McElrath	1999	114
19	Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection New England Journal of Medicine ·Luwy Musey, James P. Hughes, Timothy W. Schacker, Theresa Shea, Lawrence Corey, M. Juliana McElrath	1997	437
20	Elevated Levels of Tumor Necrosis Factor-α in Zairian Neonate Plasmas: Implications for Perinatal Infection with the Human Immunodeficiency Virus The Journal of Infectious Diseases ·Christopher C. Brown, Guido Poli, Ndongala Michel Lubaki, Michael St. Louis, Farzin Davachi, Luwy Musey, 黄长华, Andrea Kovacs, Thomas C. Quinn, Anthony S. Fauci	1994	18

About Luwy Musey

Luwy Musey is a scholar working on Virology, Microbiology, Epidemiology, Immunology and Infectious Diseases, having authored 62 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (44 papers), Respiratory viral infections research (35 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers), HIV Research and Treatment (12 papers), Bacterial Infections and Vaccines (11 papers), Immune Cell Function and Interaction (9 papers), Influenza Virus Research Studies (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). The work is most often cited by research in Virology (1.0k citations), Microbiology (325 citations), Epidemiology (1.3k citations), Immunology (743 citations) and Infectious Diseases (620 citations). Luwy Musey has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include M. Juliana McElrath, Lawrence Corey, Timothy W. Schacker, James P. Hughes, Theresa Shea, John D. Grabenstein, Richard McFetridge, Jonathan Hartzel, Gretchen Tamms and Tina M. Sterling. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, The Journal of Infectious Diseases, Open Forum Infectious Diseases and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact